Biotech Events And Company Events
Opinion: A Summary of Antibody-drug Conjugates
In the past half year, FDA has approved the market launch of two Antibody-drug conjugates (ADCs), which is AdcetrisTM and Kadcyla, respectively. According to statistics, seven ADCs within 2009 to 2010 and seventy ADCs within 2011 to 2012 went into clinical trials and now the number is
New ALK Recombinant Protein Products Are Launched by Creative BioMart
Wining the Product Launch for Both Sides The newly launched Recombinant Human ALK products can be used as immunogen, as a protein standard, or in cell biology research applications and functional researches in general. For specific details, please contact us. Have you still wondered why some
What Quality Collaboration Brings for Technology Transfer?
Collaborations and transferring technology between academic research groups and companies are commonly practiced in the biology-related field. In fact, many innovative therapies or medical/industrial/clinical techniques grow from research laboratories. But first I’d like to express my
Cleveland Clinic Published Its Selection of Top Three “Groundbreaking” Pharmaceutics
As usual, Cleveland Clinic will pick out some “groundbreaking” pharmaceutics that may make big difference for healthcare industry in their late development stages. This year who will be picked by Cleveland? According to internal news, Gilead's sofosbuvir, Novartis’ heart drugs
Discussion: Will Google Invest Bio-pharmaceuticals after Its Health-care Part
Google once said it wanted to declare war against disease. When it said so, 23andMe, invested by it has serviced 200,000 people; iPierian (mainly for stem cells), invested by it was facing a big moment. Thus we don’t need to feel surprised when we hear about that Google is going to set up a
New Product: Native Lactate Dehydrogenase and the Property
In 1970s, human Lactate Dehydrogenase was broadly reported in studies and literatures, which indicated its great potential. The protein is found predominantly in muscle tissue and belongs to the lactate dehydrogenase family. Mutations in this gene have been linked to exertional myoglobinuria.
Do You Support Artificially Synthesized Virus?
Background About two months ago, 22 scientists from Holland, Hong Kong, USA and US singed an open letter that aimed to evaluate the potential risk of H7N9 by doing acquired functional mutation experiment. The letter was published on Nature and Science later. Upon the signing, many experts
Basic Research Confirmed a Rare Structure of RNA
As early as in 1961, a scientist had proposed the hypothesis that poly (rA), RNA, may form a parallel chain of double stranded structure. Lately Canadian scientists successfully confirmed the hypothesis with a short crystal RNA sequence—poly (rA) 11. Further they used data collected by
Worldwide Blockbusters’ Movements during Sep., 2013
On Sep. 23, 2013, Ablynx landed $840M AbbVie deal on next-gen Humira successor. Based on this, AbbVie has whipped out the checkbook to close a partnership with Belgian antibody specialist Ablynx on one of its lead programs, paying $175 million upfront and promising up to $665 million more in
Prediction on 2013 Nobel Prize in Physiology or Medicine
On Monday 7 October, 11:30 a.m. at the earliest - The Nobel Prize in Physiology or Medicine will be announced by Göran K. Hansson, Secretary of the Nobel Committee for Physiology or Medicine. Before this date, kinds of predictions will follow. Here, let’s take an inventory of such
Tips for Choosing an Elisa Kit (1)
ELISA kit refers to Enzyme-linked Immunosorbent Assay kit. It makes detection easier in a faster and simpler way. There are four general ELISA Kit types: direct, indirect, sandwich or competitive. Therefore there are choices in your research in choosing an Elisa kit. Generally, the basic
Discussion on the Prospect of Biosimilar Monoclonal Antibodies Drugs
In the past few years, monoclonal antibody drugs have dominated the world's largest bio-pharmaceutical drug sales, and in the coming years, monoclonal antibody drugs will continue to be the main force. The rapid development of monoclonal antibody drugs as well as the approaching of patent
Biosimilar Market in India: the Approaching of the Expiration of Herceptin Patent in India
Roche’s patent on Herceptin will soon expire in India, thus today here we briefly talk about the biosimilar market in India regarding this. According to authority information, there is still no clear trend if the local pharmaceuticals start to “march” to biosimilar market.
.png)
An Interesting Phenomenon for the Input and Output of Pharmaceutical Industry
Unlike pharmaceutical industry, many industries will have smooth progress during developing process. However, pharmaceutical industry may suffer from huge frustration even failure in their R&D process. It is estimated that the overall failure rate of developing of a new drug could reach 95%,
Industrial-academic Cooperation Trend: A Good Way to Promote Biological Studies
In the past few years, research funds for bio-pharmaceutical industry have shown a downward trend. In order to get out of this predicament, pharmaceutical companies begin to seek opportunity to work with academic institutions to develop new drugs. Especially with the approaching of expiration of
The Difference between Mouse Antibodies and Rabbit Antibodies
During past years, conventional antibodies have been widely utilized in researches, for example, protein detection via Western blot analyses, immunohistochemistry[1] and enzyme-linked immunosorbent assays (ELISA) [2]. And there are also newly developed technologies/antibodies to meet the
Simple Analysis of the Growing Market of Growth Hormone
With the overall improvement of biomedical technology and basic requirements, growth hormone (GH) market is growing rapidly in recent years. Growth hormone is the power source of growing Secreted by anterior pituitary of human brain, growth hormone is a hormone that promotes the growth of the
How Do You Think about cDNA Being Patentable
A few months ago, the discussions that does gene BRCA1/2 be patentable burst and the US Supreme Court finally rejected Myriad’s requirement, but the Court do claim that unlike gene BRCA1/2, cDNA is patentable. When it was decided that BRCA1/2 was not patentable, many attentions felt
Product News: Recombinant Human CD4
Last month, scientists found a mechanism how HIV infections destroy the immune cells. It is well known that HIV infections will gradually ruin affected person’s immune system by killing these cells that come to fight against the infections. But it is mysterious how the procedures proceed.
Who will be the Final Bidder for Onyx Pharmaceuticals Inc.?
The first-round bid for Onyx Pharmaceuticals Inc. will begin this week, as told by someone familiar with the matter. From June 30, Onyx enlisted Centerview Partners to help find bidders. Previously Onyx refused the offer from Amgen with $10 billion, $ 120 a share. Board members of
The Brief Inventory of Fines Multinational Pharmaceutical Companies Paid
Following manipulating articles in Journals, GlaxoSmithKline (GSK) entered another trouble time in China. The Public Security Department have begun to investigate its suspicion of commercial bribery, according to Beijing News report, as of July 14, at least four travel agencies were involved,
Immunocore Cooperates with GlaxoSmithKline to Target on Cancer and Viral Disease
On July 9, 2013, Immunocore announced that it has entered into a partnership with GlaxoSmithKline for multiple novel targets after signing the research and licensing agreement to discover and develop novel biological drugs—Immune mobilising mTCR Against Cancer (ImmTACs) in earlier
Company Acquisition: VWE International and United Biochemicals
On July 2, VWE International announced that it acquired United Biochemicals, but didn’t disclose the deal price. During last year, VWR acquired six labs outside of America, including Vitrium, Sovereign Group, Lab3, Labonord and Switch. VWR finished last year with net income of $3.8
What Biopharmaceutical Innovations and New Drug Discovery Bring?
There is no exact definition for innovation. While there at least should be a substantial improvement and not a small change over what is currently available, for example, the growth and maturation of high throughput screening and microarray technique. The Biopharmaceutical and drug discovery
Follow Up: Should Genes Be Patented Case was Settled
Patents on two naturally occurring human gene sequences, BRCA1 and BRCA2, isolated for the application in diagnostic tests regarding breast and ovarian cancer, were ruled invalid finally by US Supreme Court. On June 14, 2013, US Supreme Court ruled unanimously that natural human genes cannot
